Showing results (211-220 of 372) with videos related to

Sort By:
Pageof 38
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 24, 2022
The natural history of fibrodysplasia ossificans progressiva: A prospective, global 36-month studyRobert J Pignolo, Geneviève Baujat, Matthew A Brown, et al.
Journal of the American Chemical Society|May 15, 2010
Charge-mediated adsorption behavior of CO on MgO-supported Au clustersXiao Lin, Bing Yang, Hadj-Mohamed Benia, et al.
Children (Basel, Switzerland)|April 23, 2022
Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis PatientsMatthew L Stoll, Kimberly DeQuattro, Zhixiu Li, et al.
Children (Basel, Switzerland)|August 26, 2022
Correction: Stoll et al. Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis Patients. <i>Children</i> 2022, <i>9</i>, 569Matthew L Stoll, Kimberly DeQuattro, Zhixiu Li, et al.
Investigative Ophthalmology & Visual Science|December 12, 2017
Rare, Potentially Pathogenic Variants in ZNF469 Are Not Enriched in Keratoconus in a Large Australian Cohort of European DescentSionne E M Lucas, Tiger Zhou, Nicholas B Blackburn, et al.
American Journal of Human Genetics|September 26, 2002
Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKHCharlene J Williams, Yun Zhang, Andrew Timms, et al.
Arthritis Research & Therapy|October 22, 2014
An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3Jane Zochling, Felicity Newell, Jac C Charlesworth, et al.
Rheumatology International|March 14, 2020
Longitudinal associations between depressive symptoms and clinical factors in ankylosing spondylitis patients: analysis from an observational cohortMark C Hwang, Min Jae Lee, Lianne S Gensler, et al.
Annals of the Rheumatic Diseases|July 8, 2024
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trialsMatthew A Brown, Martin Rudwaleit, Floris A van Gaalen, et al.
BMC Medical Research Methodology|November 14, 2023
Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressivaRobert J Pignolo, Mona Al Mukaddam, Geneviève Baujat, et al.
Pageof 38